Work

5,6-Dihydro-5-aza-2′-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors

Year: 2013

Type: article

Source: Bioorganic & Medicinal Chemistry

DOI: 10.1016/j.bmc.2013.08.023

Authors: Jonathan M. Rawson, Richard H. Heineman, Lauren B. Beach, Jessica L. Martin, Erica K. Schnettler, Michael J. Dapp, Steven E. Patterson, Louis M. Mansky

Institution: University of Minnesota

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute on Drug Abuse, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Dental and Craniofacial Research

Awards: Towards therapy-induced lethal HIV mutagenesis, Minnesota Craniofacial Research Training Program, Training in PharmacoNeuroImmune Substance Abuse Research, Mechanisms of HIV-1 Variation, HIV Reverse Transcriptase-Mediated Mutagenesis, Opioid Impact on Trim37-Induced Restriction of HIV, Minnesota Training Program in Virology

OpenAlex ID: W2054218295

FWCI: 3.128

Cites: 50

Cited by: 27

Related to: 10